Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
25.30
0.00 (0.00%)
Oct 20, 2026, 1:30 PM CST

Formosa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,8203,9865,6546,7005,9213,390
Market Cap Growth
-15.67%-29.51%-15.62%13.17%74.66%-
Enterprise Value
2,6282,4994,0175,4725,8002,937
Last Close Price
25.3026.4037.4549.9550.5932.95

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
72.64419.7839.44214.954502.47118.82
PB Ratio
2.782.743.655.8812.678.62
P/TBV Ratio
4.114.014.698.77105.56-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
49.98263.2128.02175.534410.71102.95

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.030.020.01
Net Debt / Equity Ratio
-0.87-0.97-1.05-1.04-0.89-0.52
Net Debt / EBITDA Ratio
9.5511.0211.574.791.200.60
Net Debt / FCF Ratio
4.0513.3911.925.991.200.62
Asset Turnover
0.030.010.080.020.000.05
Inventory Turnover
5.153.14----
Quick Ratio
13.118.828.574.896.2611.55
Current Ratio
14.639.118.734.996.5612.15
Return on Equity (ROE)
-12.92%-5.56%-14.94%-40.04%-94.39%-135.15%
Return on Assets (ROA)
-5.22%-5.10%-5.72%-13.58%-30.45%-41.28%
Return on Capital Employed (ROCE)
-9.30%-9.00%-9.20%-19.30%-47.20%-56.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.98%-2.10%-3.55%-4.81%-6.86%-11.83%
FCF Yield
-7.71%-2.65%-2.40%-2.96%-5.85%-9.78%
Buyback Yield / Dilution
-1.17%-7.22%-13.48%-18.00%-13.70%-31.19%